nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—telencephalic ventricle—meningioma	0.0599	0.472	CbGeAlD
Ingenol Mebutate—PRKCA—brainstem—meningioma	0.0162	0.128	CbGeAlD
Ingenol Mebutate—PRKCD—cerebellum—meningioma	0.0145	0.114	CbGeAlD
Ingenol Mebutate—PRKCD—brain—meningioma	0.0118	0.0927	CbGeAlD
Ingenol Mebutate—PRKCA—spinal cord—meningioma	0.0101	0.0794	CbGeAlD
Ingenol Mebutate—PRKCA—cerebellum—meningioma	0.008	0.0629	CbGeAlD
Ingenol Mebutate—PRKCA—brain—meningioma	0.0065	0.0511	CbGeAlD
Ingenol Mebutate—PRKCD—p53 pathway—AKT1—meningioma	0.00457	0.00523	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Retinoic acid receptors-mediated signaling—AKT1—meningioma	0.00451	0.00516	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—ERBB2—meningioma	0.00443	0.00507	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—PDGFB—meningioma	0.00437	0.005	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AP1B1—meningioma	0.00435	0.00499	CbGpPWpGaD
Ingenol Mebutate—PRKCD—PDGFR-beta signaling pathway—PTEN—meningioma	0.00435	0.00498	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Endothelins—AKT1—meningioma	0.00433	0.00496	CbGpPWpGaD
Ingenol Mebutate—PRKCD—LPA receptor mediated events—AKT1—meningioma	0.00428	0.0049	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—AKT1—meningioma	0.00423	0.00484	CbGpPWpGaD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—AKT1—meningioma	0.00417	0.00478	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Alpha 6 Beta 4 signaling pathway—AKT1—meningioma	0.00417	0.00478	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—ERBB2—meningioma	0.00416	0.00477	CbGpPWpGaD
Ingenol Mebutate—PRKCA—TCR signaling in naïve CD4+ T cells—PTEN—meningioma	0.00416	0.00477	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—TP53—meningioma	0.00416	0.00476	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—ERBB2—meningioma	0.00414	0.00474	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—ERBB2—meningioma	0.00414	0.00474	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—ERBB2—meningioma	0.00412	0.00472	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—ERBB2—meningioma	0.0041	0.0047	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—ERBB2—meningioma	0.0041	0.0047	CbGpPWpGaD
Ingenol Mebutate—PRKCA—IL8- and CXCR2-mediated signaling events—AKT1—meningioma	0.00408	0.00467	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—meningioma	0.00408	0.00467	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—AP1B1—meningioma	0.00402	0.0046	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—PDGFB—meningioma	0.00397	0.00454	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—PDGFB—meningioma	0.00392	0.00449	CbGpPWpGaD
Ingenol Mebutate—PRKCA—TOR Signaling—AKT1—meningioma	0.00389	0.00446	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—ERBB2—meningioma	0.00386	0.00442	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—ERBB2—meningioma	0.00386	0.00442	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—ERBB2—meningioma	0.00382	0.00438	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—PDGFB—meningioma	0.00379	0.00435	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—ERBB2—meningioma	0.00379	0.00434	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—PTEN—meningioma	0.00378	0.00433	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—ERBB2—meningioma	0.00377	0.00432	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Insulin Signaling—PTEN—meningioma	0.00357	0.00409	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—PDGFB—meningioma	0.00357	0.00409	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—PTEN—meningioma	0.00355	0.00407	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—PDGFB—meningioma	0.00355	0.00407	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—PTEN—meningioma	0.00353	0.00405	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—PTEN—meningioma	0.00353	0.00405	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—PDGFB—meningioma	0.00353	0.00405	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—PTEN—meningioma	0.00351	0.00403	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—PDGFB—meningioma	0.00351	0.00403	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—AKT1—meningioma	0.00351	0.00402	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—PTEN—meningioma	0.0035	0.00401	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—PTEN—meningioma	0.0035	0.00401	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Wnt Signaling Pathway and Pluripotency—TP53—meningioma	0.00349	0.004	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—PLAUR—meningioma	0.00344	0.00394	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	0.00342	0.00391	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Regulation of mRNA stability by proteins that bind AU-rich elements—AKT1—meningioma	0.00338	0.00387	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—TP53—meningioma	0.00333	0.00382	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—PDGFB—meningioma	0.00331	0.00379	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—PDGFB—meningioma	0.00331	0.00379	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—TSHB—meningioma	0.00329	0.00377	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—PTEN—meningioma	0.00329	0.00377	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—PTEN—meningioma	0.00329	0.00377	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—PDGFB—meningioma	0.00328	0.00375	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—PTEN—meningioma	0.00326	0.00374	CbGpPWpGaD
Ingenol Mebutate—PRKCA—a6b1 and a6b4 Integrin signaling—AKT1—meningioma	0.00326	0.00373	CbGpPWpGaD
Ingenol Mebutate—PRKCD—TCR Signaling Pathway—AKT1—meningioma	0.00326	0.00373	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—PDGFB—meningioma	0.00325	0.00372	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—PDGFB—meningioma	0.00323	0.0037	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—PTEN—meningioma	0.00323	0.0037	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—PTEN—meningioma	0.00322	0.00369	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Corticotropin-releasing hormone—AKT1—meningioma	0.0032	0.00367	CbGpPWpGaD
Ingenol Mebutate—PRKCD—B Cell Receptor Signaling Pathway—AKT1—meningioma	0.00307	0.00351	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—TSHB—meningioma	0.00299	0.00343	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD34—meningioma	0.00294	0.00337	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—PDGFB—meningioma	0.00293	0.00335	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.00291	0.00334	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway Netpath—AKT1—meningioma	0.0029	0.00332	CbGpPWpGaD
Ingenol Mebutate—PRKCD—ErbB1 downstream signaling—AKT1—meningioma	0.00288	0.0033	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—TP53—meningioma	0.00287	0.00329	CbGpPWpGaD
Ingenol Mebutate—PRKCA—TCR signaling in naïve CD8+ T cells—AKT1—meningioma	0.00286	0.00327	CbGpPWpGaD
Ingenol Mebutate—PRKCD—VEGFA-VEGFR2 Pathway—AKT1—meningioma	0.00284	0.00325	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CTSL—meningioma	0.0028	0.00321	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cardiac Hypertrophic Response—AKT1—meningioma	0.00277	0.00318	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.00277	0.00317	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CTSL—meningioma	0.00277	0.00317	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Thromboxane A2 receptor signaling—AKT1—meningioma	0.00273	0.00313	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by VEGF—AKT1—meningioma	0.00268	0.00307	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—ERBB2—meningioma	0.00266	0.00304	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—ERBB2—meningioma	0.00263	0.00301	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Kit receptor signaling pathway—AKT1—meningioma	0.00262	0.003	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—SMO—meningioma	0.00254	0.00291	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—ERBB2—meningioma	0.00254	0.00291	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AP1B1—meningioma	0.0025	0.00286	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—TP53—meningioma	0.0025	0.00286	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—PTEN—meningioma	0.0025	0.00286	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Endothelins—AKT1—meningioma	0.00249	0.00285	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—PDGFB—meningioma	0.00248	0.00285	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—AKT1—meningioma	0.00243	0.00278	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—PLAU—meningioma	0.00241	0.00276	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—PDGFB—meningioma	0.0024	0.00275	CbGpPWpGaD
Ingenol Mebutate—PRKCA—TCR signaling in naïve CD4+ T cells—AKT1—meningioma	0.0024	0.00275	CbGpPWpGaD
Ingenol Mebutate—PRKCA—mTOR signaling pathway—AKT1—meningioma	0.0024	0.00275	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—AKT1—meningioma	0.0024	0.00275	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—ERBB2—meningioma	0.00239	0.00274	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CST3—meningioma	0.00239	0.00274	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—TP53—meningioma	0.00239	0.00273	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—ERBB2—meningioma	0.00238	0.00272	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—ERBB2—meningioma	0.00238	0.00272	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—ERBB2—meningioma	0.00237	0.00271	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—ERBB2—meningioma	0.00236	0.0027	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—TP53—meningioma	0.00234	0.00268	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—meningioma	0.00234	0.00268	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AP1B1—meningioma	0.00231	0.00264	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—PTEN—meningioma	0.00227	0.0026	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—PDGFB—meningioma	0.00225	0.00258	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—PTEN—meningioma	0.00224	0.00257	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—PDGFB—meningioma	0.00224	0.00256	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—AKT1—meningioma	0.00224	0.00256	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—ERBB2—meningioma	0.00222	0.00254	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—ERBB2—meningioma	0.00222	0.00254	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—PGR—meningioma	0.00222	0.00254	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—ERBB2—meningioma	0.0022	0.00252	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—ERBB2—meningioma	0.00218	0.00249	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—AKT1—meningioma	0.00218	0.00249	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—PTEN—meningioma	0.00217	0.00248	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—ERBB2—meningioma	0.00217	0.00248	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—AKT1—meningioma	0.00211	0.00242	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00209	0.00239	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Insulin Signaling—AKT1—meningioma	0.00206	0.00235	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—PTEN—meningioma	0.00205	0.00235	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—AKT1—meningioma	0.00205	0.00234	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—PTEN—meningioma	0.00204	0.00234	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—AKT1—meningioma	0.00204	0.00233	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—AKT1—meningioma	0.00204	0.00233	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—PTEN—meningioma	0.00203	0.00232	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—PTEN—meningioma	0.00203	0.00232	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—AKT1—meningioma	0.00203	0.00232	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—PTEN—meningioma	0.00202	0.00231	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—AKT1—meningioma	0.00202	0.00231	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—AKT1—meningioma	0.00202	0.00231	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—PTEN—meningioma	0.00201	0.0023	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—meningioma	0.002	0.0023	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—AKT1—meningioma	0.00198	0.00226	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PLAUR—meningioma	0.00197	0.00226	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	0.00196	0.00225	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Regulation of mRNA stability by proteins that bind AU-rich elements—AKT1—meningioma	0.00194	0.00222	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—AKT1—meningioma	0.0019	0.00217	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—AKT1—meningioma	0.0019	0.00217	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—TSHB—meningioma	0.00189	0.00217	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—PTEN—meningioma	0.00189	0.00216	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—PTEN—meningioma	0.00189	0.00216	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ALAD—meningioma	0.00188	0.00216	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—AKT1—meningioma	0.00188	0.00215	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—PTEN—meningioma	0.00187	0.00215	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—AKT1—meningioma	0.00186	0.00213	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—PTEN—meningioma	0.00186	0.00213	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—AKT1—meningioma	0.00185	0.00212	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—PTEN—meningioma	0.00185	0.00212	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—AKT1—meningioma	0.00184	0.00211	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—meningioma	0.00178	0.00204	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00178	0.00204	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TSHB—meningioma	0.00177	0.00202	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—TSHB—meningioma	0.00172	0.00197	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD34—meningioma	0.00169	0.00193	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.00168	0.00192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.00167	0.00192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—AKT1—meningioma	0.00165	0.00189	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—AKT1—meningioma	0.00163	0.00187	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CTSL—meningioma	0.00161	0.00185	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Metabolism of mRNA—AKT1—meningioma	0.0016	0.00183	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—AKT1—meningioma	0.00159	0.00182	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—AKT1—meningioma	0.00154	0.00176	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—ERBB2—meningioma	0.00151	0.00173	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SMO—meningioma	0.0015	0.00172	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—ERBB2—meningioma	0.0015	0.00172	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—SMO—meningioma	0.00146	0.00167	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PGR—meningioma	0.00144	0.00165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PDGFB—meningioma	0.00143	0.00163	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HES1—meningioma	0.00141	0.00161	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PLAU—meningioma	0.00138	0.00159	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CST3—meningioma	0.00137	0.00157	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Metabolism of RNA—AKT1—meningioma	0.00137	0.00157	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—AKT1—meningioma	0.00131	0.0015	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PDGFB—meningioma	0.0013	0.00149	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—AKT1—meningioma	0.00129	0.00148	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—PTEN—meningioma	0.00129	0.00147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PDGFB—meningioma	0.00128	0.00147	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—PTEN—meningioma	0.00128	0.00146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PGR—meningioma	0.00127	0.00146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—AKT1—meningioma	0.00125	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TSHB—meningioma	0.00121	0.00139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00121	0.00139	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PDGFB—meningioma	0.0012	0.00138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—AKT1—meningioma	0.00118	0.00135	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—AKT1—meningioma	0.00117	0.00135	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—AKT1—meningioma	0.00117	0.00134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—AKT1—meningioma	0.00117	0.00134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—AKT1—meningioma	0.00116	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—AKT1—meningioma	0.00116	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—AKT1—meningioma	0.00109	0.00125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—AKT1—meningioma	0.00109	0.00125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—AKT1—meningioma	0.00108	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—AKT1—meningioma	0.00107	0.00123	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—AKT1—meningioma	0.00107	0.00122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.00102	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TSHB—meningioma	0.00101	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HES1—meningioma	0.000985	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—meningioma	0.000969	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000965	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of mRNA—AKT1—meningioma	0.000918	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000912	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ERBB2—meningioma	0.000873	0.001	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SMO—meningioma	0.000863	0.000989	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ERBB2—meningioma	0.000861	0.000986	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PDGFB—meningioma	0.000842	0.000965	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PGR—meningioma	0.000827	0.000948	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—AKT1—meningioma	0.000818	0.000937	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HES1—meningioma	0.000808	0.000925	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ERBB2—meningioma	0.000806	0.000923	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of RNA—AKT1—meningioma	0.000786	0.000901	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PDGFB—meningioma	0.000748	0.000857	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PTEN—meningioma	0.000745	0.000853	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—AKT1—meningioma	0.000742	0.00085	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—AKT1—meningioma	0.000737	0.000844	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PTEN—meningioma	0.000734	0.000841	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PDGFB—meningioma	0.000691	0.000791	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTEN—meningioma	0.000687	0.000787	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—AKT1—meningioma	0.000683	0.000783	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HES1—meningioma	0.000566	0.000648	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ERBB2—meningioma	0.000565	0.000647	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—meningioma	0.000557	0.000638	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—meningioma	0.000525	0.000602	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AKT1—meningioma	0.000517	0.000592	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ERBB2—meningioma	0.000501	0.000574	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PDGFB—meningioma	0.000484	0.000554	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PTEN—meningioma	0.000481	0.000551	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—AKT1—meningioma	0.00047	0.000538	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AKT1—meningioma	0.00047	0.000538	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ERBB2—meningioma	0.000463	0.00053	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AKT1—meningioma	0.000429	0.000492	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PTEN—meningioma	0.000428	0.00049	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—AKT1—meningioma	0.000427	0.000489	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—AKT1—meningioma	0.000423	0.000485	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—AKT1—meningioma	0.000396	0.000454	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTEN—meningioma	0.000395	0.000452	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTEN—meningioma	0.000331	0.000379	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—meningioma	0.000329	0.000376	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ERBB2—meningioma	0.000324	0.000371	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AKT1—meningioma	0.000297	0.00034	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKT1—meningioma	0.000277	0.000318	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTEN—meningioma	0.000276	0.000317	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AKT1—meningioma	0.00027	0.000309	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AKT1—meningioma	0.000246	0.000282	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—AKT1—meningioma	0.000245	0.000281	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AKT1—meningioma	0.000228	0.000261	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AKT1—meningioma	0.000191	0.000218	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—meningioma	0.000189	0.000216	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKT1—meningioma	0.000159	0.000183	CbGpPWpGaD
